Effycacy of Rifaximin on Reverse Minimal Hepatic Encephalopathy and Elimation Small Intestinal Bacterial
Clinical trial NCT02439307 · TERMINATED
Trial details
- NCT number
- NCT02439307
- Sponsor
- Coordinación de Investigación en Salud, Mexico
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-28
- Primary completion
- 2021-07-26
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.